Pertussis in South Australia
DOI:
https://doi.org/10.33321/cdi.1998.22.15Keywords:
pertussis, history, pertussis surveillanceAbstract
This study describes trends in reports of pertussis in South Australia. Data were analysed from three sources: mortality data since 1893 from South Australian yearbooks, notification data from 1917, and hospitalisation data for pertussis or related complications since July 1985. Crude and age-specific rates of mortality, notifications and hospitalisation were compared. Pertussis peaked in 3 to 5 yearly cycles. The mortality and notification rates have generally declined over time. However, since 1993 the notification rate has remained high. The median age for pertussis notifications increased from 4 years in 1984 to 15 years in 1996. Serological testing for pertussis was included in 15% of notifications in 1985 and 90% in 1996. The age specific hospitalisation rate for pertussis was highest in infants ≤6 months. Since the turn of the century, mortality and notification rates due to pertussis have declined. Over the past decade the major burden of severe disease resulting in hospitalisation has been borne by infants ≤6 months. These infants are too young to be afforded protection from three primary immunisations against pertussis. Despite no substantial increase in mortality nor hospitalisation for pertussis in South Australia, the notification rate has remained high since 1993. This increase may be attributable to the use of more sensitive tests for pertussis, such as serology.
Downloads
References
Burgess M, Forrest J. Pertussis and the acellular vaccines. Commun Dis Intell 1996;20: 192-196.
National Health and Medical Research Council. Surveillance case definitions. Canberra: NHMRC, 1994.
The National Centre for Classification in Health. The 1996 Australian ICD-9-CM. Second edition. Australia: University of Sydney, 1996.
Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, Georgia, USA, 1994.
Lawrence AJ, Paton JC. Efficacy of enzyme-linked immunosorbent assay for rapid diagnosis of Bordetella pertussis infection. J Clin Micro 1987;25:2102-2104.
Onorato IM, Wassilak SG. Laboratory diagnosis of pertussis: the state of the art. Centers for Disease Control: Current issues in Paediatrics. Orenststein WA. editor. Pediatr Infect Dis J 1987;6:145-151.
Hansman DJ. Whooping cough: diagnosis, prevalence and prevention. MJA 1987;146:511-513.
Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. Fourth edition. New York: Churchill Livingstone, 1995.
Robertson PW, Goldberg H, Jarvie BH, Smith DD, Whybin LS. Bordetella pertussis infection: a cause of persistent cough in adults. MJA 1987;146:522-525.
Campbell PB, Masters PL, Rohwedder E. Whooping cough diagnosis: a clinical evaluation of complementing culture and immunofluorescence with enzyme-linked immunosorbent assay of pertussis immunoglobulin A in nasopharyngeal secretions. J Med Microbiol 1988;27:247-254.
Herwaldt LA. Pertussis in adults: what physicians need to know. Arch Intern Med 1991;151:1510-1512.
Nagel J, Poot-Scholtens EJ. Serum IgA antibody to Bordetella pertussis as an indicator of infection. J Med Microbiol 1983;16:417-426.
Australian Bureau of Statistics. Children's irnmunisation Australia, April 1995. Catalogue No 4352.0. Canberra: Australian Bureau of Statistics, 1996.
Cherry JD, Brunell PA, Golden GS. Report on the task force on pertussis and pertussis immunization. Pediatrics 1988;81(Suppl.):957-971.
Romanus V. Jonsell M. Bergquist S. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis 1987;6:364-371.
Andrews R, Herceg A, Roberts C. Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell 1997;21:145-148.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 1998 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
